ANTIDIABETIC ACTIVITY OF BERBERIS ASIATICA (D.C.) ROOTS
HTML Full TextANTIDIABETIC ACTIVITY OF BERBERIS ASIATICA (D.C.) ROOTS
Pradeep Singh* and S. K. Jain
Department of Pharmacognosy, Institute of Pharmacy, Bundelkhand University, Jhansi (UP), India
ABSTRACT
Barberries are a large group of evergreen shrubs, found in Lalitpur, Allahabad, Bhopal and Haldwani etc. It is an evergreen shrub. Commonly, its fruits are called as berries. This plant is generally use in case of diabetes and mouth ulcer, as a traditional use. Type 2 diabetes mellitus (formerly called NIDDM, type II or adult-onset) is characterized by insulin resistance in peripheral tissue and an insulin secretory defect of the β- cell. This is the most common form of diabetes mellitus and is highly associated with a family history of diabetes.
Keywords:
Berberis roots, Soxhlet, extraction, Antidiabetic Activity, Berberine
INTRODUCTION: Barberries is a large group of evergreen shrubs, found in Lalitpur, Allahabad, Bhopal and Haldwani etc 1. It is an evergreen shrub. Commonly, its fruits are called as berries. The plant is generally used in case of diabetes and mouth ulcer, as a traditional use 2, 1.2-1 meter height and stem up to 10 cm in diameter. Its bark is rough, furrowed, and somewhat corky. Twigs are glabrous or shortly pubescent, pale yellowish. Leaves are 2.5-6.3 cm by 1.3-3 cm oblong, elliptic, or broadly obovate, usually with large distant spinous teeth, sometime entire, very coriaceous, dark green with very prominent primary and secondary pale reticulate venation above, glaucous beneath. Petiole is absent or sometimes distinct up to 10 mm. Inflorescence a simple raceme up to 3 cm long, often with a few long- stalked flowers at the base. Pedicels 4-10 mm long, slender, often glaucous. Fruit is 7-10 mm long.
Type 2 diabetes mellitus (formerly called NIDDM, type II or adult-onset) is characterized by insulin resistance in peripheral tissue and an insulin secretory defect of the β- cell. This is the most common form of diabetes mellitus and is highly associated with a family history of diabetes 3.
Traditional uses of Berberis asiatica roots 4:
- For mouth ulcer; “As an Anti-inflammatory”
- As an Analgesic
- For antipyretic action
- As Diuretic
- As Hepatoprotective
- As an antimicrobial
- As an Antioxidant
- As a Strong wound healer
- As an Anti-rheumatic
- As an Immunogogue
- For Adaptogenic properties
- As stimulant
MATERIAL AND METHODS: Plant material: The roots of Berberis asiatica were collected from Haldwani (Uttaranchal) and authenticated at College of Agriculture, Indore. Voucher specimen was submitted in Dept. of Pharmacognosy Bundelkhand University Jhansi with Plant authentication no. BU/PCOG/397
Selection of Extract: Hydro alcoholic extract was selected for the in-vivo activity, being nontoxic. The roots were dried under shade and then powdered. The dried powdered material was subjected to extraction in Soxhlet apparatus 5.
Chemical Constituents: It contains alkaloids Berberine, Berbamine, Palmatine and Oxyacanthine. Berberine is its marker compound and it is isoquinoline alkaloid.
Pharmacological Activity: In the experiment a total of 50 rats were used. Diabetes was induced in all rats except one group (5 rats) one week before starting the experiment. The rats were divided into 5 batches one for antidiabetic study. In each batch five rats were used for every group.
Test Animals: Male wistar albino rats (160- 200 g) were used in the experiment.
- Normal rats + Saline Solution
- Rats + Alloxan
- Diabetic Rats + Dose I
- Diabetic Rats + Dose II
- Diabetic Rats + Standard Drugs
Parameters:
- Body weight
- Blood Glucose Level
- Morphological changes
- Behavioral Changes
Blood glucose level was checked by glucometer (accu-chek comfort) and blood was drawn by cutting the tail or from tail vein 6.
TABLE 1: EFFECT OF BERBERIS ASIATICA ROOTS (50% ETHANOLIC) EXTRACT ON BODY WEIGHT
TREATMENT/DAYS
|
1 DAY
|
7 DAY
|
14 DAY
|
21 DAY
|
Normal Rats | 174 ± 6.52 | 181 ± 8.22 | 189 ± 6.52 | 192 ± 7.58 |
Diabetic Rats | 155a ± 16.96 | 153a ± 13.04 | 147a ± 10.37 | 142a ± 7.58 |
Normal Rats + BA -250 | 162 ± 5.70 | 167 ± 5.70 | 175 ± 6.12 | 182 ± 6.71 |
Diabetic Rats + BA-250 | 138 ± 10.37 | 134 ± 7.58 | 145 ± 12.25 | 158b ± 9.08 |
Diabetic Rats + SD (Glibenclamide) | 135 ± 20.00 | 143 ± 18.91 | 145 ± 18.37 | 146 ± 18.51 |
SEM | 8.34 | 7.4 | 7.34 | 6.84 |
CD(p=0.05) | 17.4 | 15.44 | 15.32 | 14.27 |
Body weights of treated and non treated (extract of Berberis asiatica) Normal and diabetic rats and the diabetic rats treated with standard drug (Glibenclamide) at day 1, 7, 14 and day 21 of growth. (Fig. 1)
A: Significant at 5% as compared to treatment 'NR'
B: Significant at 5% as compared to treatment 'DR'
Figures in the parenthesis shows ±SEM
ANOVA was done by “Stat disc” software. P value is significant. Variation among column, mean is greater than expected by chance. (Table 2 and Fig. 2)
Table 2: Anova Test
NR | DR | DR + BA (250) | DR +BA (500) | DR + SD |
94.6 | 362 | 290 | 298 | 314 |
102.6 | 307 | 244 | 253.6 | 282 |
98.2 | 200 | 156.6 | 172 | 171.6 |
103.4 | 174 | 114 | 113 | 115.6 |
RESULT AND DISCUSSSION: The extract shows a stronger anti diabetic action then the standard drug, Glibenclamide. Regarding Morphological changes rats are supposed to get fungal infections and reddening of tail. Loco motor activity slows down. Sometimes body wt. Decreases in case of diabetic rats.
REFERENCES:
- “Indian herbal Pharmacopoeia”, Regional Research Laboratory, Jammu and Indian Drug Manufactures, Association, Mumbai, 1999, 174.
- Canadian Diabetes Association (CDA). “ J. Diabetes”, 2003, 27(suppl 2), S1-152.
- Khan, A. Irfan.; Khanum, Atiya "Herbal therapy for Diabetes”, Vol-I, 1st edition, published by Ukaaz publication Hyderabad, 2005, 122-38.
- Mukherjee, P. K.; “Quality Control of Herbal Drugs”, Business Horizons Pharmaceutical Publishers, Ed. 1st, 2001, 6-53
- Goodman and Gillman. The pharmacological basis of therapeutics. McGrow-Hill publication: 9 edition 1996; 1508-1515
- Nadkarni AK: Indian Materia Medica. Bombay Popular Prakashan, Bombay, Edition 3, Vol. I, 1991:1197-1198
Article Information
13
109-112
459 kB
1110
English
IJPSR
Pradeep Singh*, S. K. Jain and Shashi Alok
Department of Pharmacognosy, Institute of Pharmacy, Bundelkhand University, Jhansi (UP), India
pradeep_bpharma@sify.com
15 March, 2010
26 April, 2010
15 May, 2010
http://dx.doi.org/10.13040/IJPSR.0975-8232.1(6).109-12
01 June, 2010